GoAI
Get started
Hoshi Iryo-Sanki Co., Ltd. logo

Hoshi Iryo-Sanki Co., Ltd.

7634.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥5,300

¥0.00 · 0.00%

Aug 24, 9:51 AM JST

7634.T company overview

Historical prices · Market data may be delayed.

Company profile

Company website

Hoshi Iryo-Sanki Co., Ltd., a Japanese firm, specializes in the production and distribution of pharmaceutical-grade medical oxygen and nitrous oxide. Its business activities are structured across five distinct divisions: Medical Gas, Home Healthcare, Medical Gas Equipment Construction, Nursing Care, and Facilities Nursing. The Medical Gas division primarily handles the sale of various medical gases, including oxygen and anesthetic gases. Through its Home Healthcare division, the company offers rental services for essential medical devices, such as oxygen concentrators for home therapy, continuous positive airway pressure (CPAP) machines, and home ventilators. The Medical Gas Equipment Construction segment is responsible for the planning, installation, and subsequent maintenance and inspection of medical gas piping systems. The Nursing Care division provides a comprehensive suite of services, encompassing the rental and sale of care-related products, home modifications, and direct nursing assistance through home visits and in-home care coordination. Lastly, the Facilities Nursing division manages and operates fee-based residential nursing homes and day care centers, along with other related services. Established in 1960, the company's main offices are situated in Tokyo, Japan.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Yukio Hoshi
Listed since
Feb 21, 2000
Employees
527

Market position

52-week range

Current ¥5,300

Open
¥5,300
Previous close
¥5,300
Volume
100
0.22× average
Average volume
464
Average daily volume
Market cap
16.56B JPY
Beta
0.36
Market reference 1
50-day average
¥5,047.8
+5.00% above average
200-day average
¥5,072.93
+4.48% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
6.56B JPY
P/E (TTM)
11.9×
P/B (TTM)
0.82×
P/S (TTM)
1.06×
EV / EBITDA
2.28×
Earnings yield
8.33%
Free cash flow yield
13.08%
Dividend yield
1.70%

Profitability & efficiency

Gross margin
49.48%
Operating margin
12.76%
Net margin
8.94%
Return on equity
6.86%
Return on assets
5.13%
Return on invested capital
5.82%

Financial health

Debt / equity
0.05×
Current ratio
3.17×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends52%36%21%5%Gross margin, FY2021: 47.21%Gross margin, FY2022: 47.23%Gross margin, FY2023: 47.12%Gross margin, FY2024: 48.39%Gross margin, FY2025: 47.61%Operating margin, FY2021: 12.49%Operating margin, FY2022: 12.90%Operating margin, FY2023: 13.27%Operating margin, FY2024: 13.13%Operating margin, FY2025: 12.37%Net margin, FY2021: 8.67%Net margin, FY2022: 9.10%Net margin, FY2023: 9.50%Net margin, FY2024: 9.69%Net margin, FY2025: 8.85%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 47.21%. Gross margin FY2022 47.23%. Gross margin FY2023 47.12%. Gross margin FY2024 48.39%. Gross margin FY2025 47.61%. Operating margin FY2021 12.49%. Operating margin FY2022 12.90%. Operating margin FY2023 13.27%. Operating margin FY2024 13.13%. Operating margin FY2025 12.37%. Net margin FY2021 8.67%. Net margin FY2022 9.10%. Net margin FY2023 9.50%. Net margin FY2024 9.69%. Net margin FY2025 8.85%.

Income trends

Revenue

15.52B JPY+2.77%

Operating income

1.92B JPY-3.18%

Net income

1.37B JPY-6.20%
Income trends across reported periods16.96B JPY11.2B JPY5.43B JPY−334.09M JPYRevenue, FY2021: 12.77B JPYRevenue, FY2022: 13.78B JPYRevenue, FY2023: 14.78B JPYRevenue, FY2024: 15.1B JPYRevenue, FY2025: 15.52B JPYOperating income, FY2021: 1.6B JPYOperating income, FY2022: 1.78B JPYOperating income, FY2023: 1.96B JPYOperating income, FY2024: 1.98B JPYOperating income, FY2025: 1.92B JPYNet income, FY2021: 1.11B JPYNet income, FY2022: 1.25B JPYNet income, FY2023: 1.4B JPYNet income, FY2024: 1.46B JPYNet income, FY2025: 1.37B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 12.77B JPY. Revenue FY2022 13.78B JPY. Revenue FY2023 14.78B JPY. Revenue FY2024 15.1B JPY. Revenue FY2025 15.52B JPY. Operating income FY2021 1.6B JPY. Operating income FY2022 1.78B JPY. Operating income FY2023 1.96B JPY. Operating income FY2024 1.98B JPY. Operating income FY2025 1.92B JPY. Net income FY2021 1.11B JPY. Net income FY2022 1.25B JPY. Net income FY2023 1.4B JPY. Net income FY2024 1.46B JPY. Net income FY2025 1.37B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue15.52B JPY15.1B JPY14.78B JPY13.78B JPY12.77B JPY
Cost of goods sold8.13B JPY7.79B JPY7.81B JPY7.27B JPY6.74B JPY
Gross profit7.39B JPY7.31B JPY6.96B JPY6.51B JPY6.03B JPY
Research and development—7.87M JPY7.69M JPY13.76M JPY50.2M JPY
Selling, general, and administrative5.47B JPY5.32B JPY4.99B JPY4.72B JPY4.38B JPY
Operating expenses5.47B JPY5.33B JPY5B JPY4.73B JPY4.43B JPY
Interest income34.31M JPY12.38M JPY8.16M JPY1.64M JPY1.77M JPY
Interest expense18.27M JPY5.45M JPY4.67M JPY6.13M JPY8.25M JPY
Depreciation and amortization953.42M JPY828.81M JPY902.92M JPY932.04M JPY889.56M JPY
Operating income1.92B JPY1.98B JPY1.96B JPY1.78B JPY1.6B JPY
Net income1.37B JPY1.46B JPY1.4B JPY1.25B JPY1.11B JPY

Company facts updated Aug 24, 2026.

7634.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,008

-0.04%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,799

+0.61%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,990

+0.38%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,392.5

+0.23%

Continue in GoAI

Research 7634.T

research.disclaimer